What is Alveus Therapeutics worth?
$275.2Mlast known valuation
Alveus Therapeutics last raised $56.9M in its Later Stage VC (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Alveus Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC | $56.9M | ▮ | ▮ |
How Alveus Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alveus Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Alveus Therapeutics worth?
- Alveus Therapeutics's last known valuation is $275.2M.
- How much has Alveus Therapeutics raised?
- Alveus Therapeutics has raised $202.0M in total funding across 1 recorded rounds.
- When did Alveus Therapeutics last raise?
- Alveus Therapeutics last raised in Dec 2025 (Later Stage VC), raising $56.9M.